ARYx Therapeutics, Inc.

ARYX · OTC
Analyze with AI
9/30/2010
6/30/2010
3/31/2010
12/31/2009
Assets
Cash & Equivalents$2,954$1,404$6,297$7,409
Short-Term Investments$0$0$0$353
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$728$783$972$1,045
Total Curr. Assets$3,682$2,187$7,269$8,807
Property Plant & Equip (Net)$1,578$1,776$2,006$2,258
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$712$1,055$1,300$1,341
Total NC Assets$2,290$2,831$3,306$3,599
Other Assets$0$0$0$0
Total Assets$5,972$5,018$10,575$12,406
Liabilities
Payables$233$443$197$685
Short-Term Debt$6,825$3,337$4,102$5,183
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$731$2,374$2,946$2,813
Total Curr. Liab.$7,789$6,154$7,245$8,681
LT Debt$5,495$4,413$5,390$6,641
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$423$384$344$0
Total NC Liab.$5,918$4,797$5,734$6,641
Other Liabilities$0$0$0$0
Cap. Leases$747$850$954$1,386
Total Liabilities$13,707$10,951$12,979$15,322
Equity
Pref Stock$0$0$0$0
Common Stock$33$33$34$28
Retained Earnings-$199,650-$197,135-$193,499-$187,109
AOCI$0$0$0$0
Other Equity$191,882$191,169$191,061$184,165
Total Equity-$7,735-$5,933-$2,404-$2,916
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,972$5,018$10,575$12,406
Net Debt$9,366$6,346$3,195$4,415